4 assets in Childhood Neoplasm

Therapeutic assets addressing Childhood Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Childhood Neoplasm	Seoul National University Hospital	P2/3	BBB (73)
Irinotecan Childhood Neoplasm	EpicentRx, Inc.	P2	BBB (72)
Nivolumab Childhood Neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (48)
Radiosensitizer Rrx-001 Childhood Neoplasm	EpicentRx, Inc.	P1	CC (41)